| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 120,000 | 04 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | 04 Feb 2025 | 1 | $0 | 4 | Director | 06 Feb 2025, 08:05 |
| MCRB | Seres Therapeutics, Inc. | 04 Feb 2025 | 0 | $0 | 3 | Director | 06 Feb 2025, 08:00 |